YOLFTbeta
Humanwell Healthcare Group Co Ltd

Humanwell Healthcare Group Co Ltd

600079 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

19.87CNY-0.02 (-0.10%)

Price History

Full chart

Market Stats

Previous Close19.89
Open20.01
Day Range19.78 – 20.06
52-Week Range16.03 – 21.76
Volume15.19M
Market Cap31.29B
P/E (TTM)15.46
Forward P/E26.39
EPS1.24
Dividend Yield2.50%
Beta0.34
50-Day Avg18.25
200-Day Avg18.31

About

Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for patients who require opioid analgesia; nabuphine hydrochloride injection for use as an analgesic for anesthesia induction; alfentanil hydrochloride injection, a narcotic analgesic; remizaren besylate injection for sedation and anesthesia during non-endotracheal intubation surgery; and mifepristone preparations for pregnancy prevention or termination. It also provides zuka wood particles for colds; compound muniziqi granules to treat skin and gynecologicalconditions; urokinase injection for thromboembolic diseases; and neomycin sulfate API for the prevention and treatment of intestinal diseases in animals. In addition, the company offers progesterone, estrogen, androgen, cortical hormone, and other API products; steroid hormone products; natural plant-based medicines; central nervous system drugs; animal medicine; narcotics; and Uyghur medicine products. Further, it is involved in the production of veterinary drugs, feed additive, medical devices, and agricultural products; technical development, exchange, and transfer; leasing of medical devices; conference, exhibition, inspection, and testing; property management; pharmaceutical contract manufacturing; cleaning, washing, and disinfection; warehousing and logistics; investment management and consulting services; and production of health foods. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1988 and is based in Wuhan, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wentao Du
  • Employees17.15K
  • HeadquartersNo. 666, Gaoxin Avenue, Wuhan, China, 430075, China
  • Websitehttps://www.humanwell.com.cn

Leadership

  • Mr. Wentao DuGM & Financial Director · b. 1968
  • Mr. Qiang YinDeputy General Manager · b. 1982
  • Mr. Nanhong LiuDeputy GM & Board Secretary · b. 1979
  • Hua Qin HeAccounting Supervisor
  • Mr. Chenggang ZhengDeputy General Manager · b. 1972

Financials

Income Statement

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue53.63M61.65M86.59M92.57M137.02M134.18M188.50M241.93M558.80M571.82M592.31M747.90M758.88M705.06M1.02B1.33B2.20B3.60B5.32B6.01B7.05B10.05B12.33B15.45B18.63B21.81B20.68B20.55B22.34B24.52B25.44B23.96B
Growth (%)-+14.97%+40.45%+6.91%+48.02%-2.07%+40.48%+28.34%+130.98%+2.33%+3.58%+26.27%+1.47%-7.09%+45.29%+29.86%+65.75%+63.19%+47.77%+13.04%+17.33%+42.58%+22.65%+25.26%+20.64%+17.03%-5.17%-0.63%+8.71%+9.79%+3.71%-5.79%
Cost of Revenue36.37M41.61M60.56M58.98M75.22M74.92M102.75M127.66M341.26M357.39M340.86M443.80M453.16M385.99M534.59M624.03M1.18B2.13B3.20B3.52B4.14B6.41B7.80B9.57B11.20B13.20B12.01B11.78B12.63B13.30B14.12B12.41B
Gross Profit17.25M20.04M26.03M33.59M61.80M59.26M85.75M114.27M217.54M214.43M251.44M304.11M297.49M323.23M489.78M701.56M1.03B1.49B2.12B2.49B2.91B3.65B4.53B5.88B7.43B8.61B8.67B8.77B9.71B11.22B11.31B11.55B
Gross Margin32.18%32.50%30.06%36.29%45.10%44.16%45.49%47.23%38.93%37.50%42.45%40.66%39.20%45.84%47.81%52.74%46.50%41.32%39.85%41.43%41.24%36.27%36.77%38.04%39.89%39.49%41.93%42.69%43.45%45.76%44.47%48.21%
Operating Expense4.35M5.27M9.84M8.70M17.33M26.69M41.28M75.58M165.50M153.23M138.69M213.17M161.61M240.12M372.05M522.33M653.78M941.70M1.40B1.75B2.11B2.66B3.28B2.85B8.88B6.77B6.58B6.52B6.19B7.78B8.79B7.73B
Operating Income12.91M14.77M16.18M24.89M44.46M32.57M44.47M38.69M52.03M61.20M112.76M90.94M135.88M83.11M117.73M179.23M371.50M545.16M714.09M743.45M794.86M984.16M1.25B3.03B-1.45B1.84B2.09B2.25B3.52B3.45B2.52B3.82B
Operating Margin24.07%23.96%18.69%26.89%32.45%24.27%23.59%15.99%9.31%10.70%19.04%12.16%17.91%11.79%11.49%13.47%16.85%15.15%13.43%12.37%11.27%9.79%10.13%19.61%-7.76%8.44%10.12%10.94%15.74%14.06%9.92%15.96%
EBITDA14.05M15.58M18.76M20.01M46.40M36.97M69.54M77.82M101.83M119.37M131.00M171.65M212.76M188.32M217.12M353.41M453.42M669.64M802.99M1.02B1.10B1.34B1.76B2.08B2.35B3.07B3.34B3.02B3.37B4.11B3.88B4.36B
EBITDA Margin26.20%25.27%21.66%21.62%33.87%27.55%36.89%32.17%18.22%20.88%22.12%22.95%28.04%26.71%21.19%26.57%20.57%18.61%15.10%16.97%15.65%13.30%14.29%13.47%12.59%14.09%16.14%14.70%15.09%16.75%15.24%18.19%
Net Income11.76M13.16M14.26M17.88M18.85M18.25M35.96M28.05M19.26M30.68M40.22M51.43M102.73M69.44M78.20M201.47M216.47M300.35M405.99M417.78M451.77M653.82M832.40M2.07B-2.36B842.54M1.01B1.32B2.48B2.13B1.33B1.86B
Net Income Margin21.94%21.34%16.46%19.32%13.76%13.60%19.08%11.60%3.45%5.37%6.79%6.88%13.54%9.85%7.63%15.15%9.82%8.35%7.64%6.95%6.41%6.50%6.75%13.39%-12.65%3.86%4.86%6.41%11.12%8.70%5.23%7.74%
R&D--------18.45M14.76M20.05M30.24M----52.03M74.49M212.17M230.37M204.07M276.52M502.15M398.48M484.13M591.16M767.55M810.47M966.86M1.46B1.47B1.50B
R&D as % of Total Revenue--------3.30%2.58%3.39%4.04%----2.36%2.07%3.99%3.83%2.89%2.75%4.07%2.58%2.60%2.71%3.71%3.94%4.33%5.96%5.78%6.26%
Interest Expense1.35M1.12M2.85M1.09M2.32M2.59M9.12M18.27M30.10M38.49M44.54M52.14M55.35M49.14M60.57M42.38M43.21M82.70M128.07M167.84M208.97M276.50M391.79M584.71M776.72M933.97M867.91M624.33M503.86M409.25M379.60M271.04M
Interest Expense % of Total Revenue2.51%1.82%3.29%1.18%1.69%1.93%4.84%7.55%5.39%6.73%7.52%6.97%7.29%6.97%5.91%3.19%1.96%2.30%2.41%2.79%2.96%2.75%3.18%3.79%4.17%4.28%4.20%3.04%2.26%1.67%1.49%1.13%

Balance Sheet

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets97.44M108.85M144.06M267.15M359.98M471.41M518.12M991.27M1.43B1.69B1.82B2.04B2.30B2.42B2.55B3.31B4.23B6.17B7.86B9.71B12.17B18.15B26.43B36.27B36.18B36.05B32.42B35.41B36.02B36.20B36.51B36.75B
Total Liabilities49.97M55.60M86.36M89.40M158.17M180.65M193.03M594.72M744.27M1.00B1.10B1.28B1.19B1.25B1.31B1.23B1.90B3.03B4.21B4.63B6.44B8.97B14.45B19.43B21.70B21.82B19.44B19.75B18.08B16.11B15.82B14.74B
Total Equity45.06M49.97M55.23M164.81M178.86M260.21M287.24M296.51M477.82M509.96M541.07M581.13M884.22M935.58M1.01B1.76B1.95B2.65B3.02B4.34B4.72B7.88B10.04B13.52B10.82B10.17B10.64B12.95B15.04B17.04B17.62B18.91B
Cash2.09M3.87M7.42M47.18M66.57M102.38M92.72M148.58M162.65M136.77M193.79M236.12M332.35M138.42M127.27M593.73M466.42M768.38M938.43M1.21B1.48B2.41B3.21B4.35B4.18B3.57B5.43B5.17B5.18B4.10B3.92B4.14B
Total Debt23.09M29.60M57.82M40.10M80.98M99.40M99.92M398.37M515.00M725.57M796.68M876.58M729.59M729.69M746.05M577.95M950.95M1.30B2.35B2.36B3.93B3.79B7.88B10.22B11.68B12.14B13.42B12.97B10.25B9.95B8.41B-
Net Debt21.00M25.72M50.40M-7.08M14.41M-2.98M7.19M249.79M352.35M588.80M602.89M640.46M397.24M591.27M618.78M-15.78M484.53M530.24M1.41B1.16B2.45B1.38B4.67B5.87B7.50B8.58B7.99B7.80B5.07B4.31B4.50B4.33B

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.73M-25.47M26.20M16.88M-69.77M48.31M70.55M127.13M84.44M55.05M34.97M154.51M111.39M94.23M172.27M498.22M502.70M311.22M526.48M38.17M602.99M2.04B1.99B2.18B2.44B1.97B2.16B2.52B
Investing Cash Flow-12.47M-10.16M-27.68M-256.10M-312.23M-228.74M-32.27M-136.52M-23.70M-175.28M20.60M-66.41M-482.93M-820.99M-706.05M-1.37B-1.06B-2.19B-5.65B-4.61B-1.01B-349.11M301.68M-1.42B1.23B-1.22B-742.03M-
Financing Cash Flow29.13M71.44M-8.07M295.09M302.15M169.12M17.89M51.72M35.48M-73.70M-66.72M378.37M244.94M954.33M714.04M1.12B722.61M2.64B5.83B5.34B-705.45M-2.67B200.13M-914.00M-4.24B-2.11B-1.50B-
Capital Expenditure9.19M2.88M20.76M157.87M105.34M92.40M54.75M76.93M41.10M50.48M29.34M117.69M297.39M560.13M805.27M910.65M897.05M828.62M1.24B1.73B1.33B821.17M1.10B1.70B3.11B1.96B1.02B732.65M
Free Cash Flow-6.46M-28.36M5.45M-141.00M-175.11M-44.09M15.80M50.20M43.34M4.57M5.63M36.82M-186.00M-465.90M-633.00M-412.43M-394.35M-517.41M-717.82M-1.70B-731.65M1.22B890.55M475.78M-672.27M8.93M1.14B1.79B
Dividends Paid10.62M16.14M17.95M32.43M45.12M49.42M56.46M58.18M65.19M69.85M83.43M56.86M68.65M82.67M188.85M225.51M273.83M420.95M468.22M566.38M1.04B87.15M66.96M160.95M244.72M587.69M1.27B1.06B
FCF to OCF-236.37%111.31%20.78%-835.47%251.00%-91.25%22.39%39.49%51.33%8.31%16.10%23.83%-166.99%-494.42%-367.44%-82.78%-78.45%-166.25%-136.34%-4442.56%-121.34%59.70%44.78%21.84%-27.54%0.45%52.83%70.91%
Dividend Paid to FCF-164.42%-56.93%329.60%-23.00%-25.77%-112.09%357.35%115.89%150.42%1526.74%1482.09%154.43%-36.91%-17.75%-29.83%-54.68%-69.44%-81.36%-65.23%-33.40%-142.16%7.16%7.52%33.83%-36.40%6581.15%111.02%59.10%

Earnings

Report DateDec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Jun 1, 2011Aug 31, 2011Oct 23, 2011Mar 28, 2012May 30, 2012Aug 29, 2012Oct 25, 2012Feb 27, 2013Apr 26, 2013Aug 28, 2013Oct 29, 2013Mar 13, 2014Apr 29, 2014Aug 14, 2014Oct 29, 2014Mar 24, 2015Apr 24, 2015Aug 11, 2015Oct 23, 2015Mar 4, 2016Apr 15, 2016Aug 26, 2016Oct 28, 2016Mar 28, 2017Apr 14, 2017Aug 29, 2017Oct 30, 2017Dec 31, 2017Apr 11, 2018Aug 29, 2018Oct 29, 2018Apr 29, 2019Aug 29, 2019Oct 30, 2019Apr 29, 2020Aug 21, 2020Oct 25, 2020Apr 28, 2021Aug 26, 2021Oct 29, 2021Apr 27, 2022Aug 24, 2022Oct 27, 2022Mar 23, 2023Apr 27, 2023Oct 26, 2023Mar 28, 2024Apr 29, 2024Jul 26, 2024Oct 29, 2024Mar 30, 2026Apr 29, 2026Aug 25, 2026
EPS Estimate-------0.050.10--0.11-0.13-0.140.100.150.120.120.13-0.140.090.12-0.130.12-0.180.180.180.180.18--0.16---------0.27-0.18-0.300.190.370.400.300.260.350.40
EPS Actual0.040.040.070.060.060.060.090.090.050.070.130.110.080.080.120.100.090.090.080.100.060.100.130.080.130.120.210.150.160.150.120.110.120.010.210.090.120.100.300.100.190.160.380.230.260.180.410.420.130.410.280.220.280.390.260.060.340.45
Surprise-------80.00%-50.00%--0.00%--38.46%--28.57%-10.00%-40.00%-33.33%-16.67%-53.85%--7.14%-11.11%8.33%-61.54%25.00%--16.67%-33.33%-38.89%-33.33%-94.44%---25.00%---------51.85%--27.78%--6.67%15.79%-24.32%-2.50%-13.33%-76.92%-2.86%12.50%
Timing-------After-hoursPre-market--After-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap31.29B
Enterprise Value33.80B
Trailing P/E15.46
Forward P/E26.39
Price / Sales1.31
Price / Book1.59
EPS1.24
Book Value11.83
Revenue (TTM)23.96B
Gross Profit (TTM)11.77B
EBITDA4.76B
Profit Margin8.47%
Operating Margin19.26%
Return on Equity12.26%
Return on Assets6.36%
Shares Outstanding1.63B
Shares Float1.19B
Beta0.34
Dividend Yield2.50%
Dividend Rate0.48
Payout Ratio25.81%

Dividends

20231×
0.16Jun 16, 2023
20221×
0.15Jul 25, 2022
20211×
0.10Jul 27, 2021
20201×
0.05Jul 28, 2020
20181×
0.16Jul 5, 2018
20171×
0.11Jun 16, 2017
20161×
0.10Jul 22, 2016
20151×
0.15Jul 22, 2015
20141×
0.06Jul 7, 2014
20131×
0.05Jul 2, 2013
20121×
0.04Jul 3, 2012
20111×
0.02Jun 8, 2011
20101×
0.02Jun 7, 2010
20091×
0.02May 14, 2009
20081×
0.01Jun 10, 2008
20071×
0.01Jun 13, 2007
20061×
0.01Jul 13, 2006
20052×
0.22Aug 19, 20050.01May 23, 2005
20041×
0.02Jun 22, 2004
20031×
0.01May 30, 2003
20021×
0.02May 29, 2002
20011×
0.01Aug 3, 2001
20001×
0.01Aug 31, 2000

Stock Splits

  • Jul 22, 20152:1
  • Jun 13, 20073:2
  • Jul 28, 20063668:3379
  • May 30, 20037:5
  • Jun 10, 20021127:1105
  • Aug 31, 200019:10
  • Sep 27, 19991818:1619